3 completed, 2 unknown, 1 terminated, 1 withdrawn. 7 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Unknown 2, Terminated 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Effect of Drugs: new trials by email Literature Review of Effect of Drugs trials Research Report on Effect of Drugs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19 Nintedanib 150 MG, Placebo - COVID-19, Nintedanib | Phase 2 | Unknown | Huilan Zhang | 96 | 2020-04-02 | 2020-04-08 |
| Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF intravitreal injection of Conbercept - Uveitis, Macular Edema | Phase 2 / Phase 3 | Terminated | Peking Union Medical College Hospital | 5 | 2019-10-12 | 2022-10-25 |
| Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma Famitinib, Ifosfamide, Camrelizumab - Effect of Drugs, Progression | Phase 1 / Phase 2 | Withdrawn | Peking University People's Hospital | 2019-08-15 | 2020-05-19 | |
| Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma Anlotinib Hydrochloride - Effect of Drugs, Quality of Life | Phase 2 | Unknown | Peking University People's Hospital | 60 | 2019-07-18 | 2019-08-05 |
| Comparison of Efficacy of Tranexamic Acid Mesotherapy Versus 0.9% Normal Saline for Melasma Tranexamic Acid, 0.9% Normal Saline - Effect of Drugs, Adverse Effects of Medical Drugs | Phase 2 / Phase 3 | Completed | Jinnah Postgraduate Medical Centre | 30 | 2018-09-01 | 2019-12-17 |
| Efficacy and Safety Evaluation of IBI308 in Patients With Extranodal NK/T Cell Lymphoma Patients Sintilimab - Effect of Drugs | Phase 2 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 28 | 2017-08-23 | 2021-01-12 |
| Remifemin Preventing the Climacteric Symptoms in Breast Cancer Remifemin - Effect of Drugs, Safety Issues | Phase 2 | Completed | Zhejiang Cancer Hospital | 85 | 2017-01-04 | 2018-07-06 |
Breast Neoplasms (1) · COVID-19 (1) · Chordoma (1) · Disease Progression (1) · Macular Edema (1) · Melanosis (1) · Neoplasms (1) · Uveitis (1)
Neoplasms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Breast Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Eye Diseases (1) · Hyperpigmentation (1) · Infections (1) · Lung Diseases (1) · Macular Degeneration (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1)
Ifosfamide (1) · Remifemin (1) · Saline Solution (1) · Tranexamic Acid (1) · black cohosh root extract (1) · camrelizumab (1) · famitinib (1) · nintedanib (1) · sintilimab (1)
Peking University People's Hospital (2) · Huilan Zhang (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Jinnah Postgraduate Medical Centre (1) · Peking Union Medical College Hospital (1) · Zhejiang Cancer Hospital (1)
China (5) · Pakistan (1)
Jian-yong Li, Master (1) · Wei Guo, M.D. and Ph.D. (1) · Wei Guo, Ph.D. and M.D. (1) · Xingfei Yu (1)